By Catherine Eckford2024-01-05T19:28:00
Newron Pharmaceuticals and Lyndra Therapeutics’ have announced positive data from key clinical trials in schizophrenia and schizoaffective disorder.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-16T10:59:00Z
2026-06-15T07:55:00Z
Sponsored by Octave, By Adam Cross
2026-06-04T09:36:00Z
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-06-15T07:55:00
Sponsored by Octave, By Adam Cross
2026-03-26T15:00:00 2026-03-26T16:00:00
Sponsored by Medable
2025-11-20T15:00:00
Sponsored by Rapid Micro Biosystems
2025-07-10T12:58:00
Sponsored by FUJIFILM Wako Pure Chemical Corporation
Site powered by Webvision Cloud